AP

Anjali Patidar

Director Designated Partner DIN 08950176
DIN 08950176 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2020
Shareholding value •••• Premium profile

About Anjali Patidar

Data last updated:

Anjali Patidar was a Designated Partner at Bharaspati Pharma Llp (2020–2025) and Additional Director at Sakksa Pharma Private Limited (2021–2023). The companies operate in Pharma.

DIN 08950176
Primary Designation Designated Partner
Industry Pharma
First Appointment 05 Nov 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Nov 20202020Active
Sakksa Pharma Private Limited U24304TG2019PTC137524
Additional Director09 Jan 20212019₹15,400 (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bharaspati Pharma Llp
Sakksa Pharma Private Limited
Premium access

Shareholding and investment profile for Anjali Patidar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anjali Patidar

Anjali Patidar was first appointed on 05 Nov 2020 as Designated Partner at Bharaspati Pharma Llp. The most recent appointment on record is 09 Jan 2021 at Sakksa Pharma Private Limited.

Anjali Patidar held 2 earlier board appointments: Bharaspati Pharma Llp (Designated Partner, 05 Nov 2020 to 01 Aug 2025); Sakksa Pharma Private Limited (Additional Director, 09 Jan 2021 to 01 Mar 2023).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available